US FDA approves Pfizer's drug for rare bleeding disorder

BioMarin Pharmaceutical

11/10/2024 18:24

Oct 11 (Reuters) - The U.S. Food and Drug Administration
approved Pfizer's  PFE.N  once-a-week injection for the two main
types of a rare bleeding disorder called hemophilia, the company
said on Friday.
    

 (Reporting by Sruthi Narasimha Chari and Christy Santhosh in
Bengaluru; Editing by Vijay Kishore)
 ((SruthiNarasimha.Chari@thomsonreuters.com))